DCF — HEALTHSOURCE SAGINAW INC.
Enterprise Value: $-36.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-36.4M
Enterprise Value
$-12.2M
PV of Cash Flows
$-24.2M
PV of Terminal Value
$-39.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $42.3M | $-1.9M | -4.0% | $-3.7M | $-3.4M |
| Year 2 | $43.6M | $-1.5M | -3.0% | $-3.4M | $-2.8M |
| Year 3 | $44.9M | $-1.1M | -2.0% | $-3.0M | $-2.3M |
| Year 4 | $46.3M | $-0.9M | -2.0% | $-2.9M | $-2.0M |
| Year 5 | $47.7M | $-0.8M | -2.0% | $-2.9M | $-1.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-36.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$41.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999998905508113
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5